Vauthey J N, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
Am J Surg. 1995 Jan;169(1):28-34; discussion 34-5. doi: 10.1016/s0002-9610(99)80106-8.
Experience with hepatocellular carcinoma (HCC) is limited in the West and factors affecting outcome after resection are not clearly defined.
Between 1970 and 1992, 106 patients (including 74 Caucasians, 31 Orientals, and 1 black) underwent hepatic resection for HCC at Memorial Sloan-Kettering Cancer Center. Clinical and histopathologic factors of outcome were analyzed.
Cirrhosis was present in 33% and 95% were Child-Pugh A. Operative mortality was 6%, 14% in cirrhotics versus 1% in non-cirrhotics (P = 0.013). Orientals had a higher prevalence of cirrhosis (68% versus 19%) (P < 0.0001) and smaller tumors (mean 8.7 cm versus 11.0 cm) (P = 0.028) compared to Caucasians. Overall survival was 41% and 32% at 5 and 10 years, respectively. By univariate analysis, survival was greater in association with the following: absence of vascular invasion (69% versus 28%, P = 0.002); absence of symptoms (66% versus 38%, P = 0.014); solitary tumor (53% versus 28%, P = 0.014); negative margins (46% versus 21%, P = 0.022); small tumor (< or = 5 cm) (75% versus 36%, P = 0.027); and presence of tumor capsule (69% versus 35%, P = 0.047). Ethnic origin, cirrhosis, necrosis and grade did not affect survival. By multivariate analysis, only vascular invasion predicted outcome (P = 0.0025, risk ratio 2.9).
One third of patients resected for HCC can be expected to survive long-term. Except for a higher incidence of cirrhosis in Orientals, no major histopathologic or prognostic differences were noted between Orientals and Caucasians undergoing resection. Early cirrhosis (Child-Pugh A) did not adversely affect survival. Vascular invasion predicted long-term outcome.
西方对于肝细胞癌(HCC)的经验有限,且影响肝切除术后预后的因素尚未明确界定。
1970年至1992年间,106例患者(包括74名白种人、31名东方人和1名黑人)在纪念斯隆凯特琳癌症中心接受了HCC肝切除术。对预后的临床和组织病理学因素进行了分析。
33%的患者存在肝硬化,95%为Child-Pugh A级。手术死亡率为6%,肝硬化患者为14%,非肝硬化患者为1%(P = 0.013)。与白种人相比,东方人肝硬化患病率更高(68%对19%)(P < 0.0001),肿瘤更小(平均8.7厘米对11.0厘米)(P = 0.028)。5年和10年总生存率分别为41%和32%。单因素分析显示,与以下因素相关的生存率更高:无血管侵犯(69%对28%,P = 0.002);无症状(66%对38%,P = 0.014);孤立肿瘤(53%对28%,P = 0.014);切缘阴性(46%对21%,P = 0.022);小肿瘤(≤5厘米)(75%对36%,P = 0.027);以及存在肿瘤包膜(69%对35%,P = 0.047)。种族、肝硬化、坏死和分级不影响生存率。多因素分析显示,只有血管侵犯可预测预后(P = 0.0025,风险比2.9)。
预计三分之一接受HCC肝切除术的患者可长期存活。除东方人肝硬化发生率较高外,接受手术的东方人和白种人之间未发现主要组织病理学或预后差异。早期肝硬化(Child-Pugh A级)对生存率无不利影响。血管侵犯可预测长期预后。